Matches in SemOpenAlex for { <https://semopenalex.org/work/W2890250414> ?p ?o ?g. }
- W2890250414 endingPage "78" @default.
- W2890250414 startingPage "71" @default.
- W2890250414 abstract "Benzodiazepines (BDZ), which potentiate the action of GABA at four subtypes of GABAA receptors (α1, α2, α3, and α5GABAARs), are highly effective against anxiety disorders, but also cause severe side effects greatly limiting their clinical application. Both, preclinical studies in genetically engineered mice, and preclinical and clinical trials with subtype-selective compounds indicate that undesired effects can in principle be avoided by targeting specific GABAAR subtypes. While there is general consensus that activity at α1GABAARs should be avoided, controversy exists as to whether α2 or α3GABAARs need to be targeted for anxiolysis. While previous experiments in GABAAR point-mutated mice demonstrated a critical role of α2GABAARs, studies solely relying on pharmacological approaches suggested a dominant contribution of α3GABAARs. As most α1GABAAR-sparing BDZ site agonists discriminate little between α2 and α3GABAARs, these claims rest almost exclusively on a single compound, TP003, that has been reported to be a selective α3GABAAR modulator. Here, we have revisited the in vitro pharmacological profile of TP003 and, in addition, tested TP003 in GABAAR triple point-mutated mice, in which only either α1, α2, or α3GABAARs were left BDZ sensitive. These experiments revealed that TP003 behaves as a partial, rather non-selective BDZ site agonist in vitro that acts in vivo through α1, α2, and α3GABAARs (α5GABAAR-mediated effects were not tested). With respect to anxiolysis, our results support a critical contribution of α2GABAARs, but not of α3GABAARs. TP003 should therefore not be considered an α3GABAAR selective agent. Previously published studies using TP003 should be interpreted with caution." @default.
- W2890250414 created "2018-09-27" @default.
- W2890250414 creator A5024194841 @default.
- W2890250414 creator A5030705192 @default.
- W2890250414 creator A5036255755 @default.
- W2890250414 creator A5037149734 @default.
- W2890250414 creator A5053006828 @default.
- W2890250414 date "2018-12-01" @default.
- W2890250414 modified "2023-10-16" @default.
- W2890250414 title "TP003 is a non-selective benzodiazepine site agonist that induces anxiolysis via α2GABAA receptors" @default.
- W2890250414 cites W1503082749 @default.
- W2890250414 cites W1553391791 @default.
- W2890250414 cites W1565551672 @default.
- W2890250414 cites W1824285989 @default.
- W2890250414 cites W1967757420 @default.
- W2890250414 cites W1970946379 @default.
- W2890250414 cites W1973651679 @default.
- W2890250414 cites W1985639681 @default.
- W2890250414 cites W1994924064 @default.
- W2890250414 cites W2001619275 @default.
- W2890250414 cites W2013775967 @default.
- W2890250414 cites W2029465256 @default.
- W2890250414 cites W2036642338 @default.
- W2890250414 cites W2058355900 @default.
- W2890250414 cites W2076336044 @default.
- W2890250414 cites W2076472126 @default.
- W2890250414 cites W2076532454 @default.
- W2890250414 cites W2076849768 @default.
- W2890250414 cites W2083623577 @default.
- W2890250414 cites W2090116461 @default.
- W2890250414 cites W2116874498 @default.
- W2890250414 cites W2121237571 @default.
- W2890250414 cites W2126143811 @default.
- W2890250414 cites W2143086898 @default.
- W2890250414 cites W2147434999 @default.
- W2890250414 cites W2148597988 @default.
- W2890250414 cites W2148815807 @default.
- W2890250414 cites W2151414518 @default.
- W2890250414 cites W2156600215 @default.
- W2890250414 cites W2160694635 @default.
- W2890250414 cites W2300274411 @default.
- W2890250414 cites W2327771395 @default.
- W2890250414 cites W2336369886 @default.
- W2890250414 cites W2467052508 @default.
- W2890250414 cites W4238573373 @default.
- W2890250414 doi "https://doi.org/10.1016/j.neuropharm.2018.09.026" @default.
- W2890250414 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30240781" @default.
- W2890250414 hasPublicationYear "2018" @default.
- W2890250414 type Work @default.
- W2890250414 sameAs 2890250414 @default.
- W2890250414 citedByCount "8" @default.
- W2890250414 countsByYear W28902504142019 @default.
- W2890250414 countsByYear W28902504142020 @default.
- W2890250414 countsByYear W28902504142022 @default.
- W2890250414 countsByYear W28902504142023 @default.
- W2890250414 crossrefType "journal-article" @default.
- W2890250414 hasAuthorship W2890250414A5024194841 @default.
- W2890250414 hasAuthorship W2890250414A5030705192 @default.
- W2890250414 hasAuthorship W2890250414A5036255755 @default.
- W2890250414 hasAuthorship W2890250414A5037149734 @default.
- W2890250414 hasAuthorship W2890250414A5053006828 @default.
- W2890250414 hasConcept C118552586 @default.
- W2890250414 hasConcept C126322002 @default.
- W2890250414 hasConcept C127413603 @default.
- W2890250414 hasConcept C150903083 @default.
- W2890250414 hasConcept C15744967 @default.
- W2890250414 hasConcept C168258287 @default.
- W2890250414 hasConcept C169760540 @default.
- W2890250414 hasConcept C170493617 @default.
- W2890250414 hasConcept C185592680 @default.
- W2890250414 hasConcept C188198153 @default.
- W2890250414 hasConcept C207001950 @default.
- W2890250414 hasConcept C2778173252 @default.
- W2890250414 hasConcept C2778938600 @default.
- W2890250414 hasConcept C38533456 @default.
- W2890250414 hasConcept C558461103 @default.
- W2890250414 hasConcept C58732023 @default.
- W2890250414 hasConcept C71924100 @default.
- W2890250414 hasConcept C78519656 @default.
- W2890250414 hasConcept C86803240 @default.
- W2890250414 hasConcept C98274493 @default.
- W2890250414 hasConceptScore W2890250414C118552586 @default.
- W2890250414 hasConceptScore W2890250414C126322002 @default.
- W2890250414 hasConceptScore W2890250414C127413603 @default.
- W2890250414 hasConceptScore W2890250414C150903083 @default.
- W2890250414 hasConceptScore W2890250414C15744967 @default.
- W2890250414 hasConceptScore W2890250414C168258287 @default.
- W2890250414 hasConceptScore W2890250414C169760540 @default.
- W2890250414 hasConceptScore W2890250414C170493617 @default.
- W2890250414 hasConceptScore W2890250414C185592680 @default.
- W2890250414 hasConceptScore W2890250414C188198153 @default.
- W2890250414 hasConceptScore W2890250414C207001950 @default.
- W2890250414 hasConceptScore W2890250414C2778173252 @default.
- W2890250414 hasConceptScore W2890250414C2778938600 @default.
- W2890250414 hasConceptScore W2890250414C38533456 @default.
- W2890250414 hasConceptScore W2890250414C558461103 @default.
- W2890250414 hasConceptScore W2890250414C58732023 @default.
- W2890250414 hasConceptScore W2890250414C71924100 @default.